The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

15 Dec 2020 07:00

RNS Number : 6275I
Catenae Innovation PLC
15 December 2020
 

15 December 2020

 

Catenae Innovation PLC

("Catenae", the "Company" or the "Group")

 

Business Update

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, further to the announcement made by the Company on 16 October 2020, it has renamed its 50/50 Joint Venture Company to Synovate Global Limited ("Synovate") and Synovate has received its first orders.

 

Synovate is a joint venture between Catenae and BHA-Medical ("BHA") in which Catenae licenses its technology platforms and BHA provides its Covid-19 CE-certified and scientifically validated by the UK Government Near-Patient Healgen Antigen test and its Covid-19 CE-certified Near-Patient Antai Triple-Antibody test.

 

Through Synovate, BHA has provided badminton's national governing body - Badminton England with its Near-Patient Healgen Antigen test kits, and Catenae has supplied its GDPR-compliant data management platform, for the Badminton Europe Qualification Group 1 matches that took place in Milton Keynes between 9 - 12 December 2020.

 

Synovate's partner, ECG Training, conducted the tests on the participating teams from England, Sweden, Estonia and Hungary, and all of the test results were securely logged and managed using Catenae's platform through Synovate. The data was then submitted to Public Health England (PHE), for input into the NHS's 'Test and Trace' platform, and the players received their test results via SMS text message and email.

 

Through Synovate, BHA's Covid-19 test kits and Catenae's data management platform have also been supplied to Stone Bailey, a security, safety and medical solutions organisation, for use at "Lapland UK", a Christmas destination event near Ascot in Surrey.

 

Under the terms of the agreement with Stone Bailey, BHA provide the CE-certified Near-Patient Antai Triple-Antibody test kits for the venue staff, and have ensured that Stone Bailey received the training required to carry out the ongoing testing procedure. All test results are securely recorded on Catenae's data management portal through Synovate and input into Public Health England.

 

Albeit neither the Badminton England nor the Stone Bailey agreements will generate significant revenues for the Company, it provides a commercial endorsement for Synovate's offering.

 

The Synovate website can be viewed at this link: www.synovateglobal.com.

 

Guy Meyer, Chief Executive Officer of Catenae, said: "We are delighted to officially launch Synovate and to be able to provide commercial organisations with a comprehensive offering that they can use to test and securely manage Covid-19 cases within their corporations. Importantly, Synovate ensures that results from both Antigen and Antibody test are fed into PHE, where, in turn, they are inputted into the NHS's 'Test and Trace' platform. Our platform is able to accept tests results from a range of differing testing procedures and is also able to accept an individual's vaccination information.

 

"Utilising the sales expertise of our newly appointed Chief Commercial Officer, Nick Delacamp, we are experiencing increased interest for Synovate's services from organisations across a range of industries, and we look forward to keeping the market updated on further progress in due course."

 

Matt Stone, Managing Director of Stone Bailey, commented: "We are proud to be leading the way in managing the safety of our teams and visitors to Lapland UK. The testing system has made it quick and easy for us to conduct the tests and inform both the end-users and Public Health England of the outcomes."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company and the Directors of the Company accept responsibility for the content of this announcement.

 

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins / Matthew McHale

 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

About Synovate Global

 

Synovate Global is a joint venture between BHA-Medical and Catenae Innovation PLC. BHA-Medical provides the most advanced technologies in the field of medicine. It combines this with clinical expertise and excellence to deliver an enriched quality of service for its customers across the globe.

 

Catenae is at the forefront of digital transformation globally. It provides a range of solutions which help organisations to better manage and control their operations through safe, secure Data Management Platforms, Digital Passport Apps and Dynamic Data Intelligence Dashboards.

 

Synovate Global's purpose is to enable businesses and organisations to operate with confidence, safety and optimal efficiency. It helps to mitigate risk and proactively manage the population's health status through cutting edge medical products, supported by clinical and occupational health services and underpinned by undisputed blockchain technology.

 

www.synovateglobal.com

 

About Badminton England

 

Badminton England is the national governing body for the sport of badminton in England. It aims to govern, encourage and develop the sport throughout England.

 

https://www.badmintonengland.co.uk/ 

 

About Stone Bailey

 

Stone Bailey is an organisation that provides a full security service and advise on safety, medical and risk management practices. Using its specialist knowledge and expertise in vigilance and diligence, it establishes a clear sense of direction to ensure it offers an exceptional service from concept to completion.

 

https://stone-bailey.com/ 

 

Forward-Looking Statements

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements.

The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFUEELESSESE
Date   Source Headline
26th Nov 20078:52 amRNSHolding(s) in Company
23rd Nov 20077:01 amRNSDirectorate Change
21st Nov 20072:33 pmRNSHolding(s) in Company
12th Nov 200711:00 amRNSHolding(s) in Company
25th Oct 20078:58 amRNSHolding(s) in Company
18th Oct 200710:57 amRNSHolding(s) in Company
17th Oct 20079:18 amRNSHolding(s) in Company
12th Oct 200711:19 amRNSHolding(s) in Company
5th Oct 20072:02 pmRNSHolding(s) in Company
3rd Oct 20077:00 amRNSHolding(s) in Company
28th Sep 20073:59 pmRNSHolding(s) in Company
28th Sep 20078:40 amRNSHolding(s) in Company
25th Sep 20074:38 pmRNSHolding(s) in Company
25th Sep 20074:15 pmRNSHolding(s) in Company
17th Aug 20077:00 amRNSAIM Rule 26
14th Jun 20077:01 amRNSInterim Results
21st May 20077:00 amRNSDirectorate Change
11th Apr 20072:42 pmRNSHolding(s) in Company
20th Mar 20079:50 amRNSHolding(s) in Company
8th Mar 20073:08 pmRNSAGM Statement
13th Feb 20077:01 amRNSFinal Results
9th Feb 20071:36 pmRNSChange of Registered Address
13th Dec 20063:19 pmRNSVoting Rights
3rd Oct 20061:03 pmRNSHolding(s) in Company
19th Sep 200611:36 amRNSHolding(s) in Company
15th Sep 20063:48 pmRNSDisposal
15th Sep 20063:29 pmRNSHolding(s) in Company
11th Sep 20063:48 pmRNSEGM Statement
7th Sep 20063:47 pmRNSHolding(s) in Company
30th Aug 200612:13 pmRNSHolding(s) in Company
29th Aug 20067:02 amRNSDisposal Agreement
21st Aug 20067:16 amRNSDisposal Agreement
4th Aug 20063:49 pmRNSProposed Disposals
30th Jun 20061:43 pmRNSInterim Results
8th Jun 20067:02 amRNSDisposal of Passion Radio Ltd
11th May 200611:42 amRNSProduct launch & RAJAR Update
28th Apr 20063:03 pmRNSResult of AGM
31st Mar 20063:04 pmRNSFinal Results
28th Feb 20063:58 pmRNSDisposal
2nd Feb 20063:53 pmRNSAudience Figures
1st Feb 20067:01 amRNSProposed Disposals
27th Oct 20059:35 amRNSRAJAR Wave 3 2005
25th Aug 20057:00 amRNSDisposal
4th Aug 20052:25 pmRNSRAJAR Q2 2005
27th Jun 20057:00 amRNSInterim Results
23rd Jun 20057:00 amRNSDirectorate Change
13th May 20055:23 pmRNSHolding(s) in Company
13th May 200511:49 amRNSSAR 3 - Milestone Group PLC
5th May 20053:09 pmRNSRAJAR Q 1
21st Apr 20054:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.